Speaking at a conference on rare diseases in Beijing, Ding Jie, vice director of the Peking University First Hospital, said many patients failed to get a correct diagnosis.
"This is because of doctors' limited medical knowledge about rare diseases, most of which are genetic and therefore difficult to confirm.
It is also difficult for diagnosed patients to receive timely treatment due to a shortage of effective drugs, most of which are imported from foreign countries. They usually take a long time to receive approval and get to market", Ding was quoted as saying by state-run Xinhua news agency.
According to the World Health Organisation, a rare disease is one that affects a small percentage of the population, ranging from 0.65 in 1,000 to 1 in 1,000. More than 6,000 rare diseases have been confirmed so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
